Botox 100 unit vials
Ended Awarded Last action
- Contract number
- SPE2DR26FFKT0
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,879
Award facts
- Contract value 100% obligated
- $2,879.22 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) issued a delivery order valued at $2,879.22 to DMS Pharmaceutical Group Inc. for BOTOX 100 Unit Vials, effective January 28, 2026, with an ultimate completion date of February 19, 2026. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was selected under a firm fixed-price contract with no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (IDC) designated SPE2DR, which was awarded by DLA on November 13, 2025, as part of the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative with a ceiling value of $499,999,999 through December 31, 2036.
The PPV-G GEN V represents DLA's broader $30.3 billion acquisition strategy to establish multiple regional prime vendor contractors capable of supplying the Department of Defense with comprehensive pharmaceutical products and medical consumables to support military healthcare facilities worldwide. Under this indefinite delivery contract structure, DLA is authorized to issue firm fixed-price delivery orders for branded and generic prescription drugs, over-the-counter medications, biologics, vaccines, and specialty pharmaceuticals. DMS Pharmaceutical Group's established performance across numerous delivery orders demonstrates its capability to fulfill the diverse pharmaceutical requirements of the federal military medical system, with no subcontractors identified in this award.
Quick answers
Who was awarded contract SPE2DR26FFKT0?
SPE2DR26FFKT0 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 28, 2026.
How much is contract SPE2DR26FFKT0 worth?
The government has obligated $2,879 on SPE2DR26FFKT0.
Is contract SPE2DR26FFKT0 an order under another contract?
Yes. SPE2DR26FFKT0 is a delivery order under SPE2DR25D9212, an indefinite delivery contract.
Was contract SPE2DR26FFKT0 competed?
The extent of competition for SPE2DR26FFKT0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award